<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83338</article-id><article-id pub-id-type="doi">10.7554/eLife.83338</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Microtubule-mediated GLUT4 trafficking is disrupted in insulin resistant skeletal muscle</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-292123"><name><surname>Knudsen</surname><given-names>Jonas R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5471-491X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-292381"><name><surname>Persson</surname><given-names>Kaspar W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292382"><name><surname>Henriquez-Olguin</surname><given-names>Carlos</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292383"><name><surname>Li</surname><given-names>Zhencheng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292391"><name><surname>Di Leo</surname><given-names>Nicolas</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6268-890X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312917"><name><surname>Hesselager</surname><given-names>Sofie A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292385"><name><surname>Raun</surname><given-names>Steffen H</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292386"><name><surname>Hingst</surname><given-names>Janne R</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-292387"><name><surname>Trouillon</surname><given-names>Raphaël</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292388"><name><surname>Wohlwend</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292389"><name><surname>Wojtaszewski</surname><given-names>Jørgen FP</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-86956"><name><surname>Gijs</surname><given-names>Martin AM</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-193525"><name><surname>Jensen</surname><given-names>Thomas Elbenhardt</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6139-8268</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Nutrition, Exercise and Sports</institution>, <institution>University of Copenhagen</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff2"><institution content-type="dept">Department of Biomedical Sciences</institution>, <institution>University of Copenhagen</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff3"><institution content-type="dept">Clinical Drug Development</institution>, <institution>Novo Nordisk</institution>, <addr-line><named-content content-type="city">Soeborg</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff4"><institution content-type="dept">Department of Electrical Engineering</institution>, <institution>Polytechnique Montréal</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><aff id="aff5"><institution content-type="dept">Institute of Bioengineering</institution>, <institution>École Polytechnique Fédérale de Lausanne</institution>, <addr-line><named-content content-type="city">Lausanne</named-content></addr-line>, <country>Switzerland</country></aff><aff id="aff6"><institution content-type="dept">Laboratory of Microsystems</institution>, <institution>École Polytechnique Fédérale de Lausanne</institution>, <addr-line><named-content content-type="city">Lausanne</named-content></addr-line>, <country>Switzerland</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1067"><name><surname>Czech</surname><given-names>Michael</given-names></name><role>Reviewing editor</role><aff><institution>University of Massachusetts Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jrk@nexs.ku.dk</email> (JK);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>tejensen@nexs.ku.dk</email> (TJ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>04</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e83338</elocation-id><history><date date-type="received"><day>08</day><month>09</month><year>2022</year></date><date date-type="accepted"><day>02</day><month>04</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Knudsen et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Knudsen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83338-v1.pdf"/><abstract><p>Microtubules serve as tracks for long-range intracellular trafficking of glucose transporter 4 (GLUT4), but the role of this process in skeletal muscle and insulin resistance is unclear. Here, we used fixed and live-cell imaging to study microtubule-based GLUT4 trafficking in human and mouse muscle fibers and L6 rat muscle cells. We found GLUT4 localized on the microtubules in mouse and human muscle fibers. Pharmacological microtubule disruption using Nocodazole (Noco) prevented long-range GLUT4 trafficking and depleted GLUT4-enriched structures at microtubule nucleation sites in a fully reversible manner. Using a perifused muscle-on-a-chip system to enable real-time glucose uptake measurements in isolated mouse skeletal muscle fibers, we observed that Noco maximally disrupted the microtubule network after 5 min without affecting insulin-stimulated glucose uptake. In contrast, a 2h Noco treatment markedly decreased insulin responsiveness of glucose uptake. Insulin resistance in mouse muscle fibers induced either <italic>in vitro</italic> by C2 ceramides or <italic>in vivo</italic> by diet-induced obesity, impaired microtubule-based GLUT4 trafficking. Transient knockdown of the microtubule motor protein kinesin-1 protein KIF5B in L6 muscle cells reduced insulin-stimulated GLUT4 translocation while pharmacological kinesin-1 inhibition in incubated mouse muscles strongly impaired insulin-stimulated glucose uptake. Thus, in adult skeletal muscle fibers, the microtubule network is essential for intramyocellular GLUT4 movement, likely functioning to maintain an insulin-responsive cell-surface recruitable GLUT4 pool via kinesin-1 mediated trafficking.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd><kwd>Rat</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009708</institution-id><institution>Novo Nordisk Fonden</institution></institution-wrap></funding-source><award-id>15182</award-id><principal-award-recipient><name><surname>Jensen</surname><given-names>Thomas Elbenhardt</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009708</institution-id><institution>Novo Nordisk Fonden</institution></institution-wrap></funding-source><award-id>16OC0023046</award-id><principal-award-recipient><name><surname>Wojtaszewski</surname><given-names>Jørgen FP</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009708</institution-id><institution>Novo Nordisk Fonden</institution></institution-wrap></funding-source><award-id>17SA0031406</award-id><principal-award-recipient><name><surname>Knudsen</surname><given-names>Jonas R</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009708</institution-id><institution>Novo Nordisk Fonden</institution></institution-wrap></funding-source><award-id>17SA0031406</award-id><principal-award-recipient><name><surname>Henriquez-Olguin</surname><given-names>Carlos</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003554</institution-id><institution>Lundbeckfonden</institution></institution-wrap></funding-source><award-id>R313-2019-643</award-id><principal-award-recipient><name><surname>Jensen</surname><given-names>Thomas Elbenhardt</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003554</institution-id><institution>Lundbeckfonden</institution></institution-wrap></funding-source><award-id>R266-2017-4358</award-id><principal-award-recipient><name><surname>Wojtaszewski</surname><given-names>Jørgen FP</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008392</institution-id><institution>Sundhed og Sygdom, Det Frie Forskningsråd</institution></institution-wrap></funding-source><award-id>FSS8020-00288B</award-id><principal-award-recipient><name><surname>Wojtaszewski</surname><given-names>Jørgen FP</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008392</institution-id><institution>Sundhed og Sygdom, Det Frie Forskningsråd</institution></institution-wrap></funding-source><award-id>#9058-00047B</award-id><principal-award-recipient><name><surname>Knudsen</surname><given-names>Jonas R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Jonas R Knudsen, Affiliated with Novo Nordisk A/S.</p></fn><fn fn-type="conflict" id="conf3"><p>Janne R Hingst, Affiliated with Novo Nordisk A/S.</p></fn><fn fn-type="conflict" id="conf4"><p>Jørgen FP Wojtaszewski, has ongoing collaborations with Pfizer inc. and Novo Nordisk A/S unrelated to this study..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were approved by the Danish Animal Experimental Inspectorate or by the local animal experimentation committee of the Canton de Vaud under license 2890 and complied with the European Union legislation as outlined by the European Directive 2010/63/EU. The current work adheres to the standards outlined in the ARRIVE reporting guidelines.</p></fn><fn fn-type="other"><p>Human subjects: The work involving human subjects was approved by the Copenhagen Ethics Committee (H-6-2014-038; Copenhagen, Denmark) and complied with the guidelines of the 2013 Declaration of Helsinki. Informed written consent was obtained from all subjects prior to entering the study.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files</p></sec><supplementary-material><ext-link xlink:href="elife-83338-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>